SM-153-EDTMP (Samarium-153-ethylenediamine-tetra methylene phosphonic acid) is an agent for palliative treatment of painful bone metastases. In 2008, the Centre for Radioisotope and Radiopharmaceuticals Technology (PTRR) of National Nuclear Energy of Agency of Indonesia (BATAN) along with Kimia Farma launched an innovation of radiopharmaceutical analgesic named T-Bone KaeF.
